3 Podcast Episodes
152: TWIN PETES INVESTING Podcast no.99: GSK Pfizer Seagen, Dechra Pharma, Merck, Prometheus Biosciences, Bellus Health, Avacta THG SOHO REIT, NETW WG. WJG HLN KAPE, Takeovers, FTSE 100, Nasdaq, AIM All-share, Elite companies, Psychology, Investing Trading &
152: TWIN PETES INVESTING Podcast no.99: GSK Pfizer Seagen, Dechra Pharma, Merck, Prometheus Biosciences, Bellus Health, Avacta THG SOHO REIT, NETW WG. WJG HLN KAPE, Takeovers, FTSE 100, Nasdaq, AIM All-share, Elite companies, Psychology, Investing Trading &
The topics, stocks and shares mentioned/discussed include: Plans for Twin Petes Investing podcast 100 Triple Point Soci... Read more
22 Apr 2023
•
1hr 29mins
042 | Bellus Health back in the game, BC Cancer Agency makes two breakthrough discoveries, and RepliCel Life Sciences gets a little help from its friends.
042 | Bellus Health back in the game, BC Cancer Agency makes two breakthrough discoveries, and RepliCel Life Sciences gets a little help from its friends.
Ahead on Biotechnology Focus Radio : Bellus Health back in the game with a new therapeutic asset, BC Cancer Agency scien... Read more
7 Mar 2017
•
14mins
022: Bellus Health reels, QLT's merger, & we relaunch our "Hot Button Issue Survey"
022: Bellus Health reels, QLT's merger, & we relaunch our "Hot Button Issue Survey"
Bellus Health is left reeling as its lead drug Kiacta fails its Phase 3 clinical study, Vancouver based QLT inks a merge... Read more
29 Jun 2016
•
11mins